| Execution period | Effective until March 31, 2027 |
|---|
NSE filing, NSE: HARIOMPIPE. Summary written from the filing by ALFA Finder's alert engine.
Hariom Pipe Industries Ltd: key numbers
- Share price
- ₹317.45
- Market cap
- ₹983.1 Cr
- Revenue (annual)
- ₹1,667 Cr
- Net profit (annual)
- ₹75.71 Cr
- P/E (TTM)
- 14.3×Sector 16.7×
- Promoter holding
- 57.26%+0.00% QoQ
- FII holding
- 10.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hariom Pipe Industries Ltd
All →Hariom Pipe Industries Board Meeting Date
Hariom Pipe Industries Limited has intimated a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window closes from 1 October 2026 until 6 November 2026.
Hariom Pipe Industries Partnership
Hariom Pipe signed a non-binding MoU with APEDB for a proposed Rs 700 crore integrated steel plant in Andhra Pradesh. Implementation remains subject to approvals and clearances.
- Value
- ₹700.0 Cr
Hariom Pipe Industries Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine compliance disclosure under Regulation 31(1)(b).
Hariom Pipe Industries Production Started
Hariom Pipe Industries' subsidiary commissioned two solar power plants with a cumulative capacity of 10 MW (AC) in Maharashtra. This adds to the Group's renewable capacity.
- solar power generation capacity
- 10.0 MW
Hariom Pipe Industries Other Announcement
The company filed its quarterly compliance certificate under SEBI Regulation 74(5) from its RTA, confirming that all shares are held in dematerialized form.
Hariom Pipe Industries Annual General Meeting
Hariom Pipe Industries Limited conducted its 19th Annual General Meeting on September 30, 2026. The proceedings covered financial adoption, director re-appointments, and dividend approval.
Other regulatory approval announcements
All →Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.
Kalyani Cast-Tech Regulatory Approval
Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.
Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Canara Bank Regulatory Approval
Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.
- Value
- ₹1,500 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.